Abiopharma

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency

Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product

Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026

LPL Financial Welcomes Fortress Financial Planning

Change - Announcement of Cessation: Resignation of Lead Independent Director - Mr Sim Mong Keang

Elanco Animal Health Inc. - Elanco Announces USDA Approval ofTruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)